Cite
HARVARD Citation
Herbrecht, R. et al. (2018). Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura. Vox sanguinis. 113 (5), pp. 459-467. [Online].